RT Journal Article
SR Electronic
T1 Cardiometabolic risk factors and preclinical target organ damage among adults in Ghana: Findings from a national study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.28.20082446
DO 10.1101/2020.04.28.20082446
A1 Li, Jie
A1 Owusu, Isaac Kofi
A1 Geng, Qingshan
A1 Folson, Aba Ankomaba
A1 Zheng, Zhichao
A1 Adu-Boakye, Yaw
A1 Dong, Xinran
A1 Wu, Wen-Chih
A1 Agyekum, Francis
A1 Fei, Hongwen
A1 Ayetey, Harold
A1 Deng, Mulan
A1 Adomako-Boateng, Fred
A1 Jiang, Zuxun
A1 Abubakari, Braimah Baba
A1 Xian, Zhao
A1 Fokuoh, Forster Nketiah
A1 Appiah, Lambert Tetteh
A1 Liu, Simin
A1 Lin, Chunying
YR 2020
UL http://medrxiv.org/content/early/2020/05/03/2020.04.28.20082446.abstract
AB Background Sub-Saharan Africa (SSA) has the highest prevalence of cardiovascular diseases (CVD). Nevertheless, very few studies have directly examined the development of and risk factors for CVD among Africans.Objective To examine CVD risk factors and outcomes particularly in the early stage of CVD development among adults in Ghana.Methods Using a stratified multistage random sampling method, 1,106 participants were recruited as a nationally representative sample of the general population ≥18 years in Ghana from 2016 to 2017. For each participant, we measured CVD risk factors and preclinical target organ damage (TOD) for CVD development.Results The prevalence of CVD risk factors was 21.1% for obesity, 10.8% for diabetes, 55.4% for hypertension, 37.3% for dyslipidemia, 12.8% for hyperuricemia, and 39.3% for hsCRP>3 mg/L in the recruited population. The prevalence of preclinical TOD was 8.6% for peripheral artery disease (PAD), 14.7% for carotid thickening, 5.9% for left ventricular hypertrophy (LVH), and 4.4% for chronic kidney disease (CKD). Three CVD risk factors appeared to play most prominent roles in TOD development, including obesity for PAD (OR 1.88, 95% CI 1.13–3.09), hypertension for carotid thickening (OR 1.57, 95% CI 0.99–2.54) and LVH (OR 6.25, 95% CI 2.98–14.50), and hyperuricemia for CKD (OR 5.56, 95% CI 2.79–11.15).Conclusions The prevalence of CVD risk factors and early outcomes have reached epidemic proportions among Ghanaian adults. The distinct patterns of risk factors in the development of TOD presents important challenges and opportunities for interventions to improve cardiometabolic health among adults in Ghana.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by China-Ghana West African Heart Center Cooperation Project (to CL) funded by the National Health Commission of People’s Republic of China. SL was partially funded by the U.S. Fulbright Scholar Program. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data can be available by contacting the corresponding authors.